3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
98
Carcinoma, Non-Small-Cell Lung
32
Neoplasms
22
Neoplasm Metastasis
14
Carcinoma, Renal Cell
13
Prostatic Neoplasms
12
Lung Neoplasms
12
Small Cell Lung Carcinoma
10
Diabetes Mellitus, Insulin-Dependent, 12
10
Pancreatic Neoplasms
7
Uveal Melanoma
6
Skin Neoplasms
6
Ovarian Neoplasms
6
Brain Neoplasms
6
Advanced Cancer
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Mesothelioma
5
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Kidney Neoplasms
4
Hodgkin Disease
4
Head and Neck Neoplasms
4
Carcinoma, Transitional Cell
4
Carcinoma, Merkel Cell
4
Carcinoma, Hepatocellular
4
Carcinoma
4
Breast Neoplasms
4
Various Advanced Cancer
3
Interventions
fluciclovine F-18
2
Positron-Emission Tomography
2
Injections
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
pembrolizumab
1
ioflupane
1
idelalisib
1
aflibercept
1
Water
1
Vertical Dimension
1
Methylene Blue
1
Mammography
1
Drug Delivery Systems
1
Diagnosis, Computer-Assisted
1
Daunorubicin
1
Cytarabine
1
Control Groups
1
CPX-351
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Disease
×
Ipilimumab
×
Clear all
No trials found.